|
Market Cap (4-Jun) $13,434,327 (1,583rd) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 21,427 |
Shortsold (14-Feb) 10,000,000 (0.20%) (406th) |
|
52w High $0.007 |
52w Low $0.002 |
P/E 0.91 |
EPS -0.01 |
ADR released this announcement to the ASX on 28 July 2022, 10:00. The announcement is marked as price sensitive, and is 11 page(s) in length and 501.89kb in size.
You can view all announcements from ADR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ADR was 0.200% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It remains ranked 406th as of the latest reported data (14 February 2023).
| Other Recent Announcements from ADR | |
|---|---|
| Application for quotation of securities - ADR | 28 June 2023, 16:25 |
| Change of Auditor | 27 June 2023, 9:41 |
| Notification of cessation of securities - ADR | 11 May 2023, 13:49 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 July 2022, 10:00 |
| Adherium receives US FDA clearance for Hailie for Ellipta | 25 July 2022, 12:08 |
| Adherium signs US distribution agreement with Perigon Health | 20 July 2022, 8:43 |
| Adherium signs UK distribution agreement with Helicon Health | 14 June 2022, 12:51 |
You must be logged in to post a reply.
Adherium 